ArticleRevista medica del Instituto Mexicano del Seguro Social2024
[Blood transfusion in patients undergoing heart transplant surgery].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early versus delayed post-transfusion hemoglobin and hematocrit measurement in adults: a narrative review.Revista medica del Instituto Mexicano del Seguro Social · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In patients undergoing cardiac surgery, one of the most common complications is bleeding. There are risk factors associated with bleeding and transfusion during or after cardiac surgery. The decision of blood transfusion depends on the individualized characteristics of each patient. Objective: To determine the characteristics that influenced blood transfusion, aside from the frequency and proportion of the use of blood components. Material and methods: We identified patients who underwent heart transplant surgery and the frequency of those who required transfusion. The proportion of the use of blood components, the characteristics of the surgical intervention and factors that influenced transfusion and mortality were determined. Results: We included 19 patients who underwent heart transplant surgery. 89.5% received blood transfusion. The mean amount of blood products used during surgery and hospitalization was 2.10 red blood cells, 1.10 fresh frozen plasma and 0.89 apheresis platelets. The odds ratio for transfusion in surgery was 1.4 for mortality. Conclusions: 89.5% of the patients required blood transfusion either in surgery (73.7%) or during hospitalization (68.4%). Age, cardiopulmonary bypass time, and length of stay represented risk for transfusion. Age over 45 years and transfusion in hospitalization increase the risk of mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.